Harlingen Medical Center Hosts 6th Annual Charity Golf Tournament

Translate to Spanish or other 102 languages!

 Mega Doctor News

- Advertisement -

HARLINGEN – Harlingen Medical Center is set to host one of the most exciting charity events of the year, The Harlingen Medical Center 6th Annual Charity Golf Tournament!  The philanthropy-centered outing will take place on Saturday, November 12, 2016, at the luxurious Rancho Viejo Resort and Country Club!  Check-in is set to begin at 7:00 a.m., at the country club’s Registration Hall (located at the resorts main entrance off of Highway 77), followed by Tee Off at 8:00 a.m.

The Harlingen Medical Center 6th Annual Charity Golf Tournament will raise funds to benefit a local charitable organization in South Texas – while giving participants an opportunity to enjoy 18-holes of golf on the beautiful greens at Rancho Viejo.  The golf course features natural terrain, barrancas, resacas, and narrow fairways with strategically designed landing areas that will be pleasing to all who play.

The charity event will also feature a hole in one GRAND PRIZE, and, a closest to the hole prize winner!  There will be plenty of raffle gift items and door prizes!  The top-three performing teams will also receive trophies and cash prizes! 

- Advertisement -

All Team Registrants will enjoy complimentary breakfast, lunch, and ice cold beverages! 

For more information regarding the charity event, team registration, and corporate sponsorships, please review the attached material.  You may also contact Manny Chacon, Business Development at Harlingen Medical Center, at Mchacon@PrimeHealthCare.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -